Growth Equity
Growth Credit
Healthcare
Contact
Menu
Investor Log in
Close
Growth Equity
Growth Credit
Healthcare
Contact
About Us
Team
Careers
Portfolio Roles
Insights
Portfolio
Investors
OneVentures
•
27 January 2014
Australia’s Hatchtech ‘itching’ to partner at J.P. Morgan
OneVentures
Learn More
You may also like
02 August 2020
Healthcare
FDA Approves Xeglyze™ for the topical treatment of head lice infestation
02 August 2020
Healthcare
Hatchtech gets lice treatment nod from FDA
01 February 2018
OneVentures
No nit picking: Head lice group Hatchtech gets green light to trials
14 September 2015
OneVentures
Hatchtech inks $279m head lice deal as VC market comes to life
View All